Osteopenia was found in more than 25% of both men and women, suggesting that more osteoporosis screening and prevention programs are needed in middle-age individuals.
A meta-analysis showed that abaloparatide treatment reduces the risk for vertebral, nonvertebral, and wrist fractures in postmenopausal women with osteoporosis compared with placebo or other medical treatments.
For young women with anorexia nervosa, oral contraceptives may limit bone loss.
Multiple pharmacologic therapies have been shown to reduce fracture rates in postmenopausal women with acceptable safety profiles
Elderly men are significantly undertreated for osteoporosis.
Statin use in elderly women with coronary artery disease may prevent bone loss.
The need for effective osteoporosis screening tools and treatment strategies is high, as the current methods have a low sensitivity for determining postmenopausal women at risk for a major osteoporotic fracture.
Ongoing treatment with bisphosphonate therapy may not be needed to prevent future fractures in certain patients due to the sustained effect of the drug.
Investigators examined the effect of consuming a Mediterranean-style diet for 1 year on inflammatory response and bone health in the elderly.
Screening with bone measurement recommended for women aged 65, younger women at risk
